Cargando…
ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer
BACKGROUND: Radiotherapy is a conventional and effective local treatment for breast cancer. However, residual or recurrent tumors appears frequently because of radioresistance. Novel predictive marker and the potential therapeutic targets of breast cancer radioresistance needs to be investigated. ME...
Autores principales: | Sun, Xiaoqing, He, Zhenyu, Guo, Ling, Wang, Caiqin, Lin, Chuyong, Ye, Liping, Wang, Xiaoqing, Li, Yue, Yang, Meisongzhu, Liu, Sailan, Hua, Xin, Wen, Wen, Lin, Chao, Long, Zhiqing, Zhang, Wenwen, Li, Han, Jian, Yunting, Zhu, Ziyuan, Wu, Xianqiu, Lin, Huanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086123/ https://www.ncbi.nlm.nih.gov/pubmed/33931075 http://dx.doi.org/10.1186/s13046-021-01932-8 |
Ejemplares similares
-
Correction to: ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer
por: Sun, Xiaoqing, et al.
Publicado: (2022) -
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
por: Ye, Liping, et al.
Publicado: (2019) -
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
por: Ye, Liping, et al.
Publicado: (2022) -
A novel ALG10/TGF-β positive regulatory loop contributes to the stemness of colorectal cancer
por: Xu, Xiaotian, et al.
Publicado: (2022) -
ANP32E induces tumorigenesis of triple‐negative breast cancer cells by upregulating E2F1
por: Xiong, Zhenchong, et al.
Publicado: (2018)